Blueberry Therapeutics are delighted to have won an SBRI NHS contract to progress their smart wound dressing technology through Feasibility studies. The contract will allow Blueberry to complete preclinical feasibility studies of a hydrogel based SMART wound dressing for the treatment of Chronic Diabetic Foot Ulcers. Dave Cook CSO of Blueberry commented “Working with our collaborators at the Welsh Wound Innovation Centre and Public Health England, we are now progressing our research into developing a range of new dressings with beneficial properties for patients with chronic wounds such as diabetic foot ulcers.”